News
After rebuffing Biogen, Sage pairs off with Supernus
Sage Therapeutics has agreed to be acquired by Supernus Pharma in a deal valued at around $571 million.
Sales & Marketing
US drug pricing overhaul: The Inflation Reduction Act (IRA) ...
The Inflation Reduction Act (IRA), signed into law in August 2022, marked a historic shift in US healthcare policy by granting Medicare the authority to negotiate prices for certain high-co
News
DMD gene therapy Elevidys linked to new liver failure case
Another death from liver failure has been seen with Roche and Sarepta's Duchenne muscular dystrophy therapy Elevidys, prompting a pause on treatment.
News
US lawmakers seek ban on DTC advertising
US Senators Bernie Sanders and Angus King have introduced a bill that seeks to ban direct-to-consumer (DTC) advertising by the pharma industry.
News
Moderna's RSV shot gets US nod for use in younger adults
The label for Moderna's RSV vaccine mResvia has been expanded to include adults aged 18 and over in the US, but will that lead to an uptick in sales?
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
